Ying Zhou, PhD

Co-Founder, President, Global CTO of ReLive

Managing Director of CO.DON GmbH

Ying is a renowned leader with a PhD in Biochemistry from Boston University, School of Medicine. With over a decade of experience in the pharmaceutical and bio-pharmaceutical industries, including roles at AstraZeneca, Ambergen, and Alkermes, she has made significant contributions to Drug Discovery and Development.

Ying co-founded ReLive Biotechnologies, a global regenerative medicine company group focused on cell therapies, orthopedics, and plastic & reconstructive surgery. This innovative venture operates in the United States, Europe, and China, with a mission to transform the field of tissue engineering and regenerative medicine. Under her visionary leadership, ReLive Biotechnology acquired all assets from CO.DON AG in January 2023, positioning the company as a front-runner in the industry. Driven by her passion for scientific advancement and her commitment to improve patient care, Dr. Zhou continues to pave the way for groundbreaking treatments that harness the body's natural regenerative capabilities, which could significantly improve the patients' quality of life.